- Home
- SIBN vs BDN Comparison
SIBN vs BDN Comparison
Compare SIBN & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- BDN
- Stock Information
- Founded
- SIBN 2008
- BDN 1986
- Country
- SIBN United States
- BDN United States
- Employees
- SIBN N/A
- BDN N/A
- Industry
- SIBN Medical/Dental Instruments
- BDN Real Estate Investment Trusts
- Sector
- SIBN Health Care
- BDN Real Estate
- Exchange
- SIBN Nasdaq
- BDN Nasdaq
- Market Cap
- SIBN 805.4M
- BDN 731.6M
- IPO Year
- SIBN 2018
- BDN N/A
- Fundamental
- Price
- SIBN $18.47
- BDN $4.17
- Analyst Decision
- SIBN Strong Buy
- BDN Hold
- Analyst Count
- SIBN 5
- BDN 1
- Target Price
- SIBN $24.40
- BDN $5.00
- AVG Volume (30 Days)
- SIBN 531.1K
- BDN 2.5M
- Earning Date
- SIBN 08-04-2025
- BDN 07-23-2025
- Dividend Yield
- SIBN N/A
- BDN 14.56%
- EPS Growth
- SIBN N/A
- BDN N/A
- EPS
- SIBN N/A
- BDN N/A
- Revenue
- SIBN $176,601,000.00
- BDN $312,538,000.00
- Revenue This Year
- SIBN $19.48
- BDN $57.76
- Revenue Next Year
- SIBN $16.86
- BDN $5.16
- P/E Ratio
- SIBN N/A
- BDN N/A
- Revenue Growth
- SIBN 22.60
- BDN N/A
- 52 Week Low
- SIBN $11.70
- BDN $3.41
- 52 Week High
- SIBN $20.05
- BDN $6.54
- Technical
- Relative Strength Index (RSI)
- SIBN 53.63
- BDN 40.51
- Support Level
- SIBN $18.02
- BDN $4.19
- Resistance Level
- SIBN $19.14
- BDN $4.44
- Average True Range (ATR)
- SIBN 0.66
- BDN 0.13
- MACD
- SIBN 0.04
- BDN -0.03
- Stochastic Oscillator
- SIBN 74.77
- BDN 10.58
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.